Evidence map›Paper›PMID 35478994›Full record

ArticleBioinformatics and biology insights2022

Modeling and Simulation of Cell Signaling Networks for Subsequent Analytics Processes Using Big Data and Machine Learning.

Máximo Eduardo Sánchez-Gutiérrez, Pedro Pablo González-Pérez

Erratum issuedAbstract read
In one paragraph

Article in Bioinformatics and biology insights, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Leveraging AI for cell biology discovery.Biochemical Society transactions · 2026
    Review
  4. Engineering signalling pathways in mammalian cells.Nature biomedical engineering · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Máximo Eduardo Sánchez-GutiérrezColegio de Ciencia y Tecnología, Universidad Autónoma de la Ciudad de México, Ciudad de México, México.ORCID https://orcid.org/0000-0003-1101-5956
Pedro Pablo González-PérezDepartamento de Matemáticas Aplicadas y Sistemas, Universidad Autónoma Metropolitana, Unidad Cuajimalpa, Ciudad de México, México.ORCID https://orcid.org/0000-0001-7223-9035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work explores how much the traditional approach to modeling and simulation of biological systems, specifically cell signaling networks, can be increased and improved by integrating big data, data mining, and machine learning techniques. Specifically, we first model, simulate, validate, and calibrate the behavior of the PI3K/AKT/mTOR cancer-related signaling pathway. Subsequently, once the behavior of the simulated signaling network matches the expected behavior, the capacity of the computational simulation is increased to grow data (data farming). First, we use big data techniques to extract, collect, filter, and store large volumes of data describing all the interactions among the simulated cell signaling system components over time. Afterward, we apply data mining and machine learning techniques-specifically, exploratory data analysis, feature selection techniques, and supervised neural network models-to the resulting biological dataset to obtain new inferences and knowledge about this biological system. The results showed how the traditional approach to the simulation of biological systems could be enhanced and improved by incorporating big data, data mining, and machine learning techniques, which significantly contributed to increasing the predictive power of the simulation.

Indexed as

Big data techniquescell signaling networksmachine learning techniquesmodeling and simulation approachpredictive analytics

Identifiers

PMID35478994
PMCPMC9036331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.